New diabetes clinical trial: Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus

Published on: December 07, 2023 at 11:00PM
Conditions: Type 2 Diabetes Mellitus
Interventions: Drug: semaglutide injection (HD1916); Drug: Ozempic
Sponsors: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Not yet recruiting
https://ift.tt/3CTE9rM